Longevity Biomedical (Longevity Biomedical) EV-to-FCF : (As of May. 17, 2024)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Longevity Biomedical's Enterprise Value is $0.00 Mil. Longevity Biomedical does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Longevity Biomedical's EV-to-FCF at this moment.

The historical rank and industry rank for Longevity Biomedical's EV-to-FCF or its related term are showing as below:

LBIO's EV-to-FCF is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.68
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Longevity Biomedical's stock price is $0.00. Longevity Biomedical does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Longevity Biomedical's PE Ratio at this moment.

Longevity Biomedical EV-to-FCF Historical Data

The historical data trend for Longevity Biomedical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical EV-to-FCF Chart

Longevity Biomedical Annual Data

Trend

EV-to-FCF

Longevity Biomedical Semi-Annual Data

EV-to-FCF

Competitive Comparison of Longevity Biomedical's EV-to-FCF

For the Biotechnology subindustry, Longevity Biomedical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's EV-to-FCF falls into.

Longevity Biomedical EV-to-FCF Calculation

Longevity Biomedical's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	0.000	/
	=

Longevity Biomedical (NAS:LBIO) EV-to-FCF Explanation

Longevity Biomedical's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.00	/
	=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Longevity Biomedical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » EV-to-FCF

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines